Teresa Grieco


Titolo Pubblicato in Anno
Syphilis, the Great Imitator—Clinical and Dermoscopic Features of a Rare Presentation of Secondary Syphilis INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH 2023
Semeiotica Medica e Metodologia Clinica, 3ª ed 2023
Atopic Dermatitis and Ulcerative Colitis Successfully Treated with Upadacitinib MEDICINA 2023
Telogen effluvium in SARS-CoV-2 infection: Histological aspects JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY 2023
A 52-week update of a multicentre Italian real-world experience on effectiveness and safety of dupilumab in adolescents with moderate-to-severe atopic dermatitis JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY 2023
Successful use of dupilumab for the treatment of atopic dermatitis on the genitals. a neglected anatomical site CLINICAL AND EXPERIMENTAL DERMATOLOGY 2022
Effects of Vaccination against COVID-19 in Chronic Spontaneous and Inducible Urticaria (CSU/CIU) Patients: A Monocentric Study JOURNAL OF CLINICAL MEDICINE 2022
Cutaneous reactions to covid-19 vaccines in a monocentric study. a case series JOURNAL OF CLINICAL MEDICINE 2022
It's Never Too Late To Treat Chronic Spontaneous Urticaria With Omalizumab: Real-Life Data From A Multicenter Observational Study Focusing on Elderly Patients DERMATOLOGIC THERAPY 2021
New onset of alopecia areata in a patient with SARS-CoV-2 infection: Possible pathogenetic correlations? JOURNAL OF COSMETIC DERMATOLOGY 2021
Atopic dermatitis in adolescents. effectiveness and safety of dupilumab in a 16-week real-life experience during the COVID-19 pandemic in italy DERMATOLOGIC THERAPY 2021
Effectiveness and safety of long-term dupilumab treatment in elderly patients with atopic dermatitis. a multicenter real-life observational study AMERICAN JOURNAL OF CLINICAL DERMATOLOGY 2021
Effects of dupilumab in type 1 neurofibromatosis coexisting with severe atopic dermatitis ANAIS BRASILEIROS DE DERMATOLOGIA 2021
Telogen effluvium after SARS-CoV-2 Infection. a series of cases and possible pathogenetic mechanisms SKIN APPENDAGE DISORDERS 2021
COVID-19. important updates and developments edited by franco rongioletti, MD, and leonard hoenig, MD Impact of COVID-19 on patients with atopic dermatitis CLINICS IN DERMATOLOGY 2021
Dupilumab in adolescents with moderate to severe atopic dermatitis. a 32-week real-world experience during the COVID-19 pandemic CLINICAL AND EXPERIMENTAL DERMATOLOGY 2021
Cutaneous adverse reactions after COVID-19 vaccines in a cohort of 2740 italian subjects. an observational study DERMATOLOGIC THERAPY 2021
Lymphomatoid drug reaction developed after BNT162b2 (Comirnaty) COVID-19 vaccine manifesting as pityriasis lichenoides et varioliformis acuta-like eruption JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY 2021
Dupilumab facial redness: histologic characterization on a series of four cases IMMUNOTHERAPY 2021
Management of patients with atopic dermatitis undergoing systemic therapy during COVID-19 pandemic in italy. data from the DA-COVID-19 registry ALLERGY 2021

© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma